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Recent studies (1-4) have shown that the endothelial cell has multiple hemo- 
static properties. The presence of thrombomodulin (1) and anticoagulant hepa- 
rin-like molecules on the cell surface (2), and the elaboration of prostacyclin (3) 
and plasminogen activators (4)  provide powerful mechanisms for inhibition of 
the coagulation system. In addition to these and other anticoagulant properties, 
recent  studies  (5,  6)  have  suggested  potential  procoagulant  activities  of the 
endothelial cell. Endothelial cells can bind Factors IX and IX, (5, 6). Cell-bound 
Factor IX can be activated, and cell-bound Factor IXa, in the presence of Factor 
VIII, can promote Factor X activation (7, 8). Factor X also binds to endothelium 
(5,  7),  and  Factor  Xa  incubated  with  endothelial  cells  promotes  prothrombin 
activation (8, 9). This reaction is dependent on Factor V, which is expressed by 
the endothelium (8-10). Furthermore, perturbation of endothelial cells by agents 
such as endotoxin results in  the  induction of tissue  factor activity (7,  1 1-13). 
These  studies suggest that endothelial cells can potentially play a  role  in pro- 
coagulant (14), in addition to anticoagulant, reactions. 
An important determinant of the coagulant activity of cell-associated coagula- 
tion proteins concerns their cellular processing. If an enzyme remains localized 
on the cell surface, its activity can be modulated by the cells while it remains in 
contact  with  its  substrates  and  inhibitors  in  the  plasma.  In  addition,  cellular 
binding can initiate clearance via endocytosis and degradation. Previous studies 
have indicated that coagulation Factor X  (5, 7) and its activated form, Factor Xa 
(8,  15),  bind specifically to distinct sites on the endothelial cell surface.  In this 
study, we  have  examined the cellular processing  of bound Factors X  and  X~. 
The  results  indicate that cell-bound  Factor X  is  internalized slowly compared 
with its dissociation from the cell surface. In contrast, Factor Xa is internalized 
more rapidly, and is subsequently degraded, presumably via a lysosomal-depend- 
ent  pathway.  Activation  of Factor  X  on  the  endothelial  cell  surface  leads  to 
formation of bound  Factor  X,,  which  is  subject  to  cellular processing.  Thus, 
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internalization  and  degradation  of  Factor  X,  may  be  important  mechanisms 
regulating participation  of cell-bound Factor Xa in coagulation. 
Materials  and  Methods 
Coagulation  Factors.  Bovine coagulation factors were used throughout these studies. 
Bovine Factor X was purified to homogeneity (100 U/rag) by the method of Fujikawa et 
al. (16). Factor X was radioiodinated by the method of Bolton and Hunter (17), using N- 
succinimidyl 3-(4-hydroxy, 5-[125I]iodophenyl) propionate  (Amersham  Corp.,  Arlington 
Heights,  1L),  with  a  specific activity of 1,950  Ci/mmol.  After evaporation  to dryness, 
Bolton and Hunter reagent (2 mCi) was incubated with Factor X (10 #g) in borate buffer 
(0.1  M,  pH  8.8) for 35  min at  4°C.  The reaction  mixture  was cbromatographed on a 
Sephadex G25 column (0.9 x  20 cm) to remove excess Bolton and Hunter reagent. The 
specific radioactivity of ~5I-Factor X  was 2,500-8,500  cpm/ng over seven iodinations, 
and Factor X coagulant activity was not affected by the radiolabelling procedure. Sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 1 of l~SI-Factor X (Fig.  1, 
open circles) demonstrated  that the  heavy chain was labelled.  Radioiodinated  Factor X 
was activated immediately after labelling by incubation with the coagulant protein from 
Russell's viper venom (18) coupled to CNBr-Sepharose in the presence of 5  mM CaCI~, 
as described (8).  SDS-PAGE of 125I-Factor X, (Fig.  1, filled circles) showed the radiolabel 
remained in the heavy chain after activation. 
Bovine Factor IX was purified to homogeneity (260 U/rag) by the method of Fujikawa 
et  al.  (19).  Factor  IX  was  activated  by  incubation  with  Factor  XIa  bound  to  CNBr- 
Sepharose in the presence of 5  mM CaCl2 as described previously (6).  Factor IXa (22.2 
#M) was inactivated  by incubation with dansyl-glutamine-glycine-arginine-chloromethyl- 
ketone (600 #M) for 3 h at 25°C, as described by Lollar and Fass (20). The product had 
no  residual  coagulant  activity.  Bovine  Factor  VIII-von Willebrand  Factor  (vWF)  was 
prepared  by the  method of Newman et al.  (21).  Subsequently,  it was chromatographed 
on an antifibronectin  and antifibrinogen affinity column.  The final material  was homo- 
geneous on reduced SDS-PAGE (5%), showing one band of tool wt 200,000, correspond- 
ing to vWF. The Factor VIII/vWF preparation  used in this work had a protein concen- 
tration  of  1.1  mg/ml  and  a  Factor  VIII coagulant  activity  of 60  U/ml.  Factor  VIII 
coagulant activity in this preparation  was stable over 6  mo of storage at -80°C, and no 
other coagulant activities  (including factors VII, IX,  X,  XI, and  XII) were detected  by 
clotting  assay  (22).  Bovine  prothrombin  was  purified  to  homogeneity  (13  U/mg),  as 
described (23). 
SDS-PAGE was carried out by the method of Weber and Osborn (24) using tube gels 
6  cm in  length.  Gels  were sliced by hand into  l-ram  sections, and counted in an  LKG 
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FIGURE  1.  Reduced SDS-PAGE (7.5%) of 1251-Factor X  (O) and  X, (0).  SDS-PAGE was 
carried out, and gels were sliced and counted as described  in Materials and Methods. 
i Abbreviations used in this paper:  SDS-PAGE, sodium dodecyl sulfate-polyacrylamide  gel electro- 
phoresis; vWF, von Willebrand  Factor. NAWROTH  ET  AL.  561 
(Rockland, MD) Rackgamma counter. Electrophoresis molecular weight-calibration pro- 
teins were purchased from Pharmacia Fine Chemicals (Piscataway,  N  J). 
Cell Culture.  Bovine aortic endothelial  cells were isolated from calf aortas (a gift of 
the  Great  American Veal  Co.,  Newark,  N  J),  as  described by Schwartz (25),  and  were 
grown in Dulbecco's modified Eagle's medium with penicillin-streptomycin (50 U/ml, 50 
tsg/ml,  respectively) and  10%  fetal  calf serum  (lot  100413;  Hyclone, Sterile  Systems, 
Logan, UT). The cultures were maintained at 37°C in an atmosphere of 5% CO2 in air. 
The cells were separated for subculture with 0.25% trypsin with 0.05%  EDTA (Gibco, 
Grand Island, NY). Cells (passages  3-22) from different aortas were grown to confluence 
in  35  mm dishes (Corning Glass  Works,  Corning, NY),  and at confluence, there were 
1.1-1.5  x  10  ~ cells/cm  ~.  Experiments  were  carried  out  1  d  after  the  cells  achieved 
confluence. The cells were characterized morphologically by contact inhibition of growth, 
and cobblestone appearance in the monolayer (25),  the presence of vWF antigen using 
indirect immunofluorescence (26),  and angiotensin-converting enzyme activity (27).  Vi- 
ability during the experiments was assessed by trypan blue exclusion and was >90% at all 
times during these experiments. 
Binding and Internalization  Studies.  Before an experiment, monolayers were washed 
three times over 20 min with incubation buffer (10 mM Hepes, pH 7.45, containing 137 
mM  NaCI,  4  mM  KCI,  11  mM  glucose,  2.5  mM CaCI2, and  0.5  mg/ml bovine serum 
albumin-fatty acid free).  Then fresh incubation buffer (1.0 ml)  was added, along with 
radiolabelled  Factor X  or Xa,  and  other proteins as  indicated.  At the  specified  times, 
unbound ligand was removed by washing six times with ice-cold incubation buffer. Cell- 
associated radioactivity was characterized as surface bound, based on elution during a 3- 
min incubation at 4°C with incubation buffer containing dextran sulfate (10  mg/ml,  1 
ml)  (see  Results),  or  internalized,  if it  remained  cell-associated  after  dextran  sulfate 
treatment and could then be eluted with Tris-buffered saline (0.05 M Tris, 0.10 M NaCI, 
pH 7.45) containing Nonidet P-40 (1%;  1 ml). Elution of radioactivity with Nonidet P-40 
was complete after 10 min at 37 ° C. Cellular degradation of l~SI-Factor X and l~SI-Factor 
Xa was assessed  by trichloroacetic acid precipitation and immunoreactivity (28) determi- 
nations. Tracer precipitability was tested in 5% trichloroacetic acid, since this concentra- 
tion  of trichloroacetic acid precipitated  >95%  of the  125I-Factor  X  or  125I-Factor  Xa 
before incubation with the cells. The immunoreactivity of radiolabelled Factors X and Xa 
was tested using a monospecific rabbit antibody against Factor X (16) (generously provided 
by Dr.  K.  Fujikawa,  Department  of Biochemistry, University of Washington,  Seattle), 
which also reacts with Factor Xa.  Antibody (1/5,000 dilution; 50 tA) was incubated with 
the tracer (10 ~1) for 12 h at 4°C, then staphylococcal protein A (10% suspension; 50 #1) 
(Enzyme Center, Boston, MA) was added for 30 min at room temperature, and the tubes 
were centrifuged at 10,000 g for 3 rain.  The supernatants were aspirated, and the pellets 
were counted. Monospecific antibody to bovine antithrombin III was generously provided 
by Dr. Kurachi (Department of Biochemistry,,  Universits,  of Washinlglton). 
Dissociation  of bound lz~I-Factor X or 125I-Factor  Xa was measured as described by 
Lollar et al.  (29):  after the monolayers were incubated with tracer and washed free of 
unbound material,  incubation buffer (1.5  ml)  was added.  At the  indicated times,  cells 
were washed with incubation buffer, and the remaining cell-associated  radioactivity was 
determined using Tris-buffered saline  (0.05  M Tris,  0.1  M  NaCI, pH  7.45) containing 
Nonidet  P-40  (1%).  Increasing the  volume of incubation  buffer to  10  ml  during the 
dissociation period had no effect on the rate or extent of dissociation. 
Chloroquine treatment of endothelium was carried out by preincubating the cells with 
chloroquine (80  ~M)  in  incubation buffer for 2  h  at  37°C,  then  adding radiolabelled 
proteins. 
In other experiments (Fig.  6), cells were incubated with radioligand for 4 h at 4°C to 
allow surface binding. Monolayers were then washed six times,  and incubation buffer (1.0 
ml), prewarmed to 37°C, was added. At the indicated times,  radioactivity in the super- 
natant and associated with the cells was determined as described above. 
During the course of these experiments, monolayers were assessed for detachment and 
release of lactate dehydrogenase (Sigma Chemical Co., St.  Louis, MO) into the medium. 562  CELI.ULAR  PROCESSING  OF  BOVINE  FACTORS  X  AND  Xa 
Cell detachment was negligible throughout the experiments, and there was no increase in 
the lactate dehydrogenase activity (30) in the supernatant. 
Activation  Studies.  Endothelial cell monolayers were washed three times with incuba- 
tion buffer over 20 rain. Fresh incubation buffer (1.0 ml at 37°C) was then added, along 
with Factor IXa and Factor VIII/vWF. 30 s later, ~25I-Factor X was added. Formation of 
Factor X~ was monitored by the generation of amidolytic activity in the Bz-Ile-Glu-Gly- 
Arg-pNA synthetic substrate assay (Helena Laboratories, Beaumont, TX) (31) and cleav- 
age on SDS-PAGE (32).  The Factor X. amidolytic assay was carried out by withdrawing 
one aliquot (0.1  ml) from each well at the indicated time, and adding it to 0.5 ml of 50 
mM Tris-HC1 (pH 7.8),  175 mM NaCI, 10 mM EDTA, and 0.5 mg/ml ovalbumin. The 
entire sample was then  placed in  a  cuvette along with  synthetic substrate (0.1  ml;  2.0 
raM), and the change in optical density at 405 nm was monitored. The amount of Factor 
X, formed was determined by comparison with the linear portion of a standard curve in 
which known amounts of Factor X, were assayed under identical conditions. 
Collodial  Gold Labelling and Electron  Microscopy.  Suspensions of colloidal gold were 
prepared  (33)  with  an  average  diameter  of  18.6  +  2.7  nm  (mean  __+  SD)  and  at  a 
concentration  of 1.72  x  I0 ~2 particles/ml (34).  Colloidal gold-protein conjugates were 
prepared at pH 5.8, and complete surface labelling was achieved, as determined by the 
serial  electrolyte test  (35),  Labelled colloids  were  evaluated  for  stability as previously 
described (36). Bovine serum albumin-colloidal gold conjugates were prepared at pH 5.0, 
as a control for nonspecific binding. Experiments were then carried out as described for 
radioligands.  Internalization  was  evaluated  by  direct  gold  counting,  and  results  are 
expressed as gold particles per cell. 
For electron microscopic examination, monolayers were fixed with buffered glutaral- 
dehyde  (3%),  postfixed in  osmium tetroxide  (37),  and  stained  in  tannic  acid  (0.25%). 
Samples were then dehydrated, and embedded. For scanning electron microscopy, mono- 
layers were fixed,  stained,  dehydrated,  and critical-point dried.  Sampled were sputter- 
coated with gold-palladium and 4-5 micrographs were taken of each sample for cell area 
analysis. Cell area was 1,000 •m2/cell.  Quantitation of gold binding (38) was carried out 
by  counting  only  single  particles  within  8  nm  from  the  outer  leaflet  of the  plasma 
membrane.  20  micrographs  were  counted  from  each  sample,  duplicate  samples were 
obtained at each time point, and the experiments were performed twice. 
Results 
Incubation  of cultured  endothelium  with  ~25I-Factor  X  and  12SI-Factor  Xa 
resulted  in  a  time-dependent  association  of radioligands  with  the  cells (Fig.  2). 
Simultaneous  addition  of a  hundred-fold  molar  excess of unlabelled  Factor  X 
blocked  v25I-Factor  X-endothelial  cell  binding,  but  similar  concentrations  of 
Factors IX, IXa, Xa, and protbrombin had no effect, as was reported previously 
(5, 7). Similarly, excess unlabelled Factor X, blocked 125I-Factor Xa-endothelial 
cell binding,  but Factors IX, IXa, X, and prothrombin had no effect (see also 8). 
Thus, the binding of Factors X and Xa involve specific interactions of each ligand 
with distinct cellular binding sites. Although binding reached an apparent max- 
imum  for both  proteins  by 30  rain  at  4°C,  at  higher  temperatures,  21 °C and 
37°C,  there  was  a  steady  increase  in  the  cellular  association  of both  ligands. 
Dissociation  studies  showed  that  specific  binding  was  completely reversible  at 
4°C,  but  not at  37°C  (Fig.  2).  This suggested that at  37°C,  either  irreversible 
surface binding  bad occurred  or,  alternatively,  the cell-bound  ligand  had  been 
internalized.  To  distinguish  between  these  possibilities,  methods  to  quantitate 
surface-bound  ligand  were studied.  Dextran  sulfate completely eluted  all  125I- 
Factor X  or X, bound at 4°C after a  3-rain incubation.  Dextran sulfate did not 
result in endothelial  cell detachment.  Gentle treatment of the  monolayers with NAWROTH  ET  AL.  563 
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F~CURE  2.  Binding and uptake of 1251-Factor X and X~. Endothelial cell monolayers (1.2 × 
106 cells/well)  were incubated at 4 °C (0), 21 °C (A) or 37 °C (O) with 1 ml of incubation buffer 
containing either l~l-Factor X (1  nM) (A) or Xa (1  nM) (B). A duplicate set of wells was 
incubated with the same tracer in the presence ofa 100-fold molar excess of unlabelled ligand 
(nonspecific binding). At the indicated times, the cells were washed six times with incubation 
buffer at  4°C,  then  solubilized using incubation buffer containing Nonidet P-40 (1%) as 
described in Materials and Methods. Specific binding (total -  nonspecific binding) is plotted 
against incubation time. Dotted lines indicate dissociation studies employing the method of 
infinite dilution were carried out in parallel. Each point is the mean of duplicates and the 
experiments were repeated three times. 
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trypsin (1 mg/ml for 5 min) also dissociated cell-bound radioactivity when binding 
was  carried  out  at  4°C.  This  exposure of cells  to  trypsin  did  not  disrupt  the 
monolayer or affect cell  viability,  as  determined  by trypan  blue  exclusion.  In 
contrast, when binding was carried out at 37 °C, both dextran sulfate and trypsin 
effected only partial  dissociation  of cell-associated  ~25I-Factor X  and  Xa.  This 
was analogous to the results depicted in  Fig.  2, where dissociation studies were 
carried  out  by the  infinite dilution  (29)  method.  These  results  suggested  that 
internalization of both ligands (see below) could be responsible for formation of 
the pool of cell-associated radioligands at 37 °C resistant to dissociation by these 
multiple methods. This pool of radioligand was elutable by solubilizing the cells 
using nonionic detergent (1% Nonidet P-40), and is referred to as the internalized 
pool. In contrast to previous results (8) demonstrating covalent linkage of Factor 
X,,  to  the  surface  of bovine  aortic  vessel  segments,  no  similar  complex  was 
detectable in SDS-PAGE of the cultured endothelial cells (data not shown). Cell- 
bound ~25I-Factor X and Xa migrated similarly to the unbound proteins on SDS- 
PAGE.  Pilot  studies  with  an  antibody  to  antithrombin  IlI,  which  can  block 
formation  of Factor  X,,-antithrombin  III  complexes (8),  showed  no effect on 
Factor X~, binding and internalization. 
Prompted by these findings, internalization studies were carried out with ]25I- 
Factor  X  and  X,  (Fig.  3).  In  both  cases,  surface binding  reached an  apparent 
maximum by 30 rain, and a pool of internalized radioligand formed and increased 
steadily up to 180 rain. A  greater proportion of the cell-bound ~25I-Factor Xa is 
internalized and  degraded  compared  with  ~25I-Factor  X.  Degradation  of 125I- 
Factor X,, was progressive during incubation with the cells, based on decreased 
precipitation of radiolabelled material in trichloroacetic acid (Fig. 3), and loss of 
immunoreactivity  (Fig.  4).  Degradation  occurred  only  at  37°C,  and  in  the 564  CELLULAR  PROCESSING  OF  BOVINE  FACTORS  X  AND  X. 
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F[CURE 3.  Uptake and degradation of l~l-Factor  X  and Xa.  Endothelial cell monolayers 
(1.3 ×  106 cells/well) were incubated with I ml of incubation buffer at 37 °C for the indicated 
times with J~SI-Factor X  (1  nM) (a) or  X, (1  nM) (B). The amount of surface bound (0), 
internalized  (A),  and  degraded  (©)  ligand  was  determined  as  described  in  Materials  and 
Methods.  Each point is the mean of duplicate wells, and the experiment was repeated five 
times. Data is normalized to 106 cells. 
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FIGURE 4.  Immunoreactivity of 12~l-Factor X (0) and Xa (©) during incubation with endo- 
thelial ceils (1.4  ×  106 cells/well).  Endothelial cells were incubated with  1 ml of incubation 
buffer containing l~S1-Factor Xa (1  nM) or X  (1  nM) at 37°C.  Immunoreactivity was deter- 
ndned as described in Materials and Methods. Data shown are the mean of duplicates and the 
experiment was repeated three times. 
presence of the endothelial cells. Addition of chloroquine (an agent that blocks 
intracellular  degradation  of a  variety of radioligands  [30]) to the cultures pre- 
vented degradation  of Factor X~ (Fig.  5),  and resulted in a  marked increase in 
the apparent size of the internalized pool. In contrast, Factor X was internalized, 
but not significantly degraded (Figs.  3 a and 4). Over eight independent exper- 
iments, the overall rate of ~5I-Factor X  and X, uptake (the sum of the radioli- 
gand  bound,  internalized,  and  degraded) at a  concentration  of 1 nM, assessed 
over the first 30 rain, averaged 0.5 and 3.2 fmol/min/106 cells, respectively. The 
rate  of ~251-Factor  X,  degradation  averaged  0.9  fmol/min/106  cells over  120 
rain,  whereas the  rate  of Factor  X  degradation  was negligible  up to  140  rain. 
Specificity of the cellular  uptake of 125I-Factor X  and  Xa was indicated by the 
80-00%  inhibition  of binding and internalization  in the presence of a  100-fold 
molar excess of unlabelled protein. 
These results suggested that Factor X, cellular processing consisted of surface 
binding followed by internalization  and degradation.  Factor X was internalized, NAWROTH  El"  AL.  565 
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FIGURE 5.  Effect of chloroquine on degradation of l~51-Factor Xa by endothelial cells (1.3 
×  106 cells/well). The protocol was identical to that in Fig.  3, except that the 12SI-Factor Xa 
concentration  is  0.2  nM,  and  chloroquine  (80  #M)  was  added  where  indicated.  Symbols 
125  6  --  represent the amount of degraded  l-Factor Xa per 10  cells in the presence (O) and absence 
(O) of chloroquine. Data shown are the mean of duplicates and the experiment was repeated 
four times. 
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FIGURE 6.  Endocytosis of surface-bound ]~51-Factor X and Xa. Endothelial cell monolayers 
(1.3 x  106 cells/well) were preincubated for 4 h  at 4°C with 125I-Factor X (1 nM) (A) or Xa 
(1  nM) (B).  Monolayers were  washed six times with incubation buffer at 4°C,  then rapidly 
warmed  to  37°C  by adding 0.9  ml  incubation buffer at  37°C.  At the indicated times, an 
aliquot of supernatant was obtained and counted (x). Formation of trichloroacetic acid-soluble 
radioactivity in the supernatant was determined (O). Then the cells were washed three times 
with incubation buffer, and surface-bound (0) and internalized (&) ligand were quantitated. 
The  mean  of  duplicates  is  shown  and  the  experiment  was  repeated  four  times.  Data  is 
normalized to 106 cells. 
though at a  considerably slower rate, and was not appreciably degraded.  Con- 
sistent with these hypotheses, pulse-chase experiments (Fig. 6) demonstrated that 
Factor X~, bound to the cell surface at 4°C was subsequently internalized at an 
initial rate of 0.38 fmol/min/106 cells, and degraded at 0.40 fmol/min/106 cells. 
Similar experiments with Factor X  demonstrated a  considerably slower rate of 
internalization (0.07  fmol/min/106 cells),  and a  negligible  rate of degradation 
over the first 60 min. Cellular processing of Factor X thus occur  s slowly compared 
with Factor X~,. Internalized Factor X is returned to the cell surface and medium 566  CELLULAR  PROCESSING OF  BOVINE FACTORS  X  AND  X~ 
undegraded.  Another difference in  Factor X, and  Factor X  cellular handling is 
the accelerated dissociation of the enzyme at low pH (Fig.  7). Thus, Factor Xa-- 
binding site complexes can dissociate in acidic intracellular compartments, allow- 
ing Factor X,, to enter lysosomes, where degradation proceeds. Factor X  binding 
is  relatively  more  constant  over  the  pH  range  of  5-8,  thus  preventing  its 
accumulation in acidic intracellular structures. 
Morphologic studies  using colloidal gold conjugates prepared with  Factor X 
and Factor X~ (Fig.  8), confirmed the results of radioligand binding studies.  At 
4°C  the gold particles were evenly distributed and  closely attached  to the cell 
surface in each case (Fig. 8, a and b). After warming the cells to 37°C, clustering 
of gold particles and uptake at coated pit regions was observed (Fig. 8, c and d). 
Finally,  Factor  X,,-gold  particles  accumulated  in  lysosome-like  structures, 
whereas internalized Factor X accumulated to only a limited extent intracellularly 
in  lysosomes or elsewhere (Fig.  8, c-f).  The close association of the  Factor X- 
gold  probes  to  the  inner  lysosomal  membrane  suggests  continued  receptor 
interaction,  and  may  account  for  the  apparent  externalization  of  Factor  X. 
Factor  X,,-gold  probes are  randomly distributed  in  the  lysosomal  lumen,  sug- 
gesting  receptor-ligand  dissociation.  Factor  X-gold  conjugates  were  shuttled 
back  to  the  cell  surface.  In  each  case,  addition  of a  100-fold  molar  excess of 
Factor X  or Factor X,, not conjugated to the gold inhibited binding and inter- 
nalization by >85%. 
The importance of endocytosis as a  clearance pathway for cell-bound Factor 
X,,  was  studied  by activating  Factor  X  on endothelial  cell monolayers (Fig.  9). 
Previous studies (7, 8) have demonstrated endothelial cell-dependent activation 
of Factor X  by Factors  IX~-VIII.  When  l'~5I-Factor X,  Factor IXa, and  Factor 
VIII/vWF  were  incubated  with  endothelial  monolayers,  Factor  Xa  amidolytic 
activity was detectable in the supernatant in parallel with the appearance of 129I- 
Factor X~ on SDS-PAGE.  v"5I-Factor X~ was also present on the endothelial cell 
surface and in  the internalized pool as shown by SDS-PAGE (data not shown). 
During the incubation period, the precipitability of the tracer in trichloroacetic 
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FIGURE 7.  pH dependence of ~51-Factor X and Xa dissociation from the endothelial cell 
surface. Endothelial cell monolayers (1.3 X 106 cells/well) were equilibrated with incubation 
buffer at pH 7.45. Then ~51-Factor X (0) or X~ (0) was added for 20 rain at 4 °C. Monolayers 
were washed, incubated with incubation buffer at the indicated pH (time 0), and  ligand 
dissociated after 60 sec was determined  by the method of infinite dilution, as discussed in 
Materials and Methods. The ~25I-Factor X or Xa bound at 3 rain is reported as a percent of 
the ligand bound at time 0. Data shown represent the mean of duplicates and the experiment 
was repeated three times. NAWROTH  ET  AL.  567 
FIGURE 8.  Binding and  internalization of Factor  X  and  Xa conjugated  to colloidal  gold. 
Surface labelling of Factor X-gold (A) and Factor Xa-gold (B) after incubation with endothelial 
cells for 2 b at 4°C, followed by rinsing and fixation at 4°C.  In both cases, gold particles are 
randomly distributed at the outer membrane surface.  Marker bar represents 0.5 nm. After 
incubation at 4°C for 2 h, cells were rapidly warmed to 37°C to initiate endocytosis of surface- 
bound Factor X-gold (C) and Factor X~-gold (D). Endocytosis proceeds at coated pit regions 
involving clustering of the gold probes.  Marker bar represents 0.1  nm.  After 2  h  at 37°C, 
there is limited accumulation of Factor X-gold (E) in structures resembling lysosomes, whereas 
greater accumulation in these lysosomal-like structures is seen in cells labelled with Factor X~- 
gold (F). Marker bar represents 0.5 nm. 568  CELLULAR  PROCESSING  OF  BOVINE  FACTORS  X  AND  X~ 
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FK;UR~  9.  Factor  1Xa-VllI mediated  Factor X  activation on  the endothelial cell  surface: 
cellular processing of the Factor Xa formed. Endothelial cell monolayers (1.4 X l0  s cells/well) 
were incubated with Factors IXa (60 pM), VIII/vWF (0.5 U/ml), and 125I-Factor X (100 nM). 
At the indicated times, samples were removed to determine Factor Xa amidolytic activity (x), 
and cell surface-bound (@), internalized (A), and degraded (©) radioligand. 
acid steadily decreased (Fig.  9).  This was due to degradation of cell-associated 
radioligands rather than proteolytic cleavage of Factor X  by Factor IX~, since 
activation of Factor X does not decrease the trichloroacetic acid-precipitability 
of 125I-Factor X  prepared by the method of Bohon and Hunter (Fig.  1).  The 
radioligand being degraded was probably Factor Xa initially bound to the cell 
surface, since omission of Factor IX~, or addition of active site-blocked Factor 
IXa (dansyl-glu-gly-arg-Factor IXa)  in  its  place prevented Factor X  activation 
and cellular degradation of radioligands (data not shown). The total amount of 
Factor X, formed thus includes Factor Xa bound to the cell surface, released 
into the supernatant (1.6 fmol/min/106 cells over the first 10 min), and degraded 
by the cells (2 fmol/min/106 cells over the first 10 min). Thus, only 44% of the 
Factor Xa formed is released into the supernatant. The remainder is subject to 
endocytosis and degradation. 
Discussion 
The results reported here indicate that Factors X and Xa are internalized after 
association  with  their  specific  endothelial  cell  binding  sites.  The  Factor  X,- 
binding site complex then probably dissociates in acidic prelysosomal compart- 
ments, allowing Factor X~ to enter lysosomes, where degradation occurs. Factor 
X~, cellular processing is thus analogous to that described for low density lipopro- 
tein (40), asialoglycoproteins (41), and a variety of other ligands (39). In contrast, 
Factor X  is slowly internalized, and principally shuttled back to the cell surface 
in a  manner similar to the transferrin pathway (reviewed in  39).  This cellular 
processing of cell-bound coagulation factors indicates that the endothelial cell 
surface is not a passive template for assembly of coagulation factor complexes, 
but is a dynamic surface with its own regulatory mechanisms. 
Several mechanisms have been described by which endothelial cells can regu- 
late the coagulant activity of serine proteases.  In each case, these mechanisms 
are distinct from the pathway described in this work, involving specific binding 
sites for Factor X and Factor X~,. Anticoagulant heparin-like molecules have been 
isolated from vascular tissues (42),  and their functional activity has been dem- 
onstrated in animal infusion studies (2). Antithrombin III, a plasma glycoprotein NAWROTH  ET  AL.  569 
that  inhibits  a  number  of serine  proteases,  including  those  involved in  blood 
Coagulation (43), binds to these heparin-like  molecules on the surface of native 
endothelium, resulting in enhanced anticoagulant  activity (44). The cell surface 
thus provides heparin-like cofactor activity enhancing antithrombin III-mediated 
inactivation of multiple coagulation enzymes. Protease nexins, especially type I, 
are  secretory  proteins  that  covalently  complex  with  the  active  site  of serine 
proteases  (45).  The  enzyme-protease  nexin  complex  then  binds  to  the  cell 
surface, with subsequent internalization  and degradation (45). Formation of the 
enzyme-protease nexin  complex is the signal  for cell-surface binding  followed 
by cellular  processing.  In  addition,  covalent (46,  47)  and  noncovalent  (1,  48) 
thrombin-endothelial  cell interactions have been shown to modulate coagulant 
activity of the  cell-associated enzyme.  In  each  of these  cases,  endothelial  cells 
inactivate  or  modulate  serine  protease  activity,  though  only  in  the  case  of 
thrombin (1) and the Factor X/X, studies reported here are the cellular binding 
sites specific for only one protease. 
When  Factor X~, is added to cultured endothelial  cells, only a  small fraction, 
1-8%, binds to the monolayers allowing for cellular processing. This suggests 
that  Factor X~, generated in the fluid phase would predominately remain in the 
supernatant,  even  in  the  presence  of cells.  Mechanisms  such  as  the  heparin- 
antithrombin  III system may be the principal inactivators under these conditions. 
Alternatively, when the surface/volume ratio is increased, as in the microvascu- 
lature,  and  Factor  X  activation  occurs  on  the  cell  surface,  then  mechanisms 
involving clearance of cell-associated Factor Xa may become important.  Factor 
X  activation  on the endothelial  cell surface (Fig.  9) results in the formation of 
Factor X,, amidolytic activity in the supernatant,  but this represents only 44% of 
the  total  Factor  Xa  generated.  The  remainder  becomes internalized  and  de- 
graded, and thus does not enter the fluid phase as intact Factor Xa. 
Recent studies (49) have shown that endothelial cells can participate in a series 
of procoagulant  reactions  terminating  in  the  formation  of a  fibrin  clot closely 
associated with the cell surface. These reactions can be initiated by activation of 
cell-bound Factor IX by the intrinsic or extrinsic pathway (7).  Once Factor IXa 
is formed, an endothelial cell-localized Factor IXa-VIII-X complex assembles, 
and results in the activation of Factor X  (50). When Factor Xa is formed on the 
cell  surface,  it  can  associate  with  endothelial  cell  Factor  V  (10),  promoting 
activation of prothrombin  (8, 9), or it can be removed from the cell surface by 
endocytosis. This  prompts  the  hypothesis that  endocytosis and  degradation  of 
cell-bound Factor X,, the physiologic prothrombin activator, provides a pathway 
for regulation of procoagulant events on the vessel surface. 
Summary 
Previous studies have shown that  Factor X and  Factor Xa bind specifically to 
distinct sites on the endothelial cell surface. Since the coagulant activity of a cell- 
bound clotting protein is dependent on its remaining on the cell surface, endo- 
cytosis and degradation  studies have been carried out. Cell-bound Factor X  was 
internalized  at 0.07  fmol/min/106 cells, a rate slower than its dissociation from 
the cell surface.  Endocytosed Factor X  was not degraded,  but was returned  to 
the cell surface.  In contrast,  Factor Xa was internalized at an initial rate of 0.38 570  CELLULAR  PROCESSING  OF  BOVINE  FACTORS  X  AND  Xa 
fmol/min/10 ~ cells  and  subsequently  degraded  at  about  the  same  rate.  The 
degradation  of Factor  Xa was prevented  by chloroquine.  These  results suggest 
that Factor X, is internalized and degraded  by a  lysosomal-dependent pathway. 
Studies  with  Factor  X-  and  X~-colloidal  gold  conjugates  showed  endocytosis 
proceeding at coated pit regions, and accumulation of Factor Xa-gold particles 
in lysosome-like structures.  Endocytosis was studied  as a  clearance pathway for 
cell-bound  Factor  X~ by activating Factor  X  with  Factors  IX~ and  VIII on  the 
endothelial  cell surface.  Endocytosis of the  Factor X~ formed was significant, as 
only 44%  of the  Factor X,  formed  was released into  the  supernatant,  whereas 
the  remainder  was internalized  and  degraded.  Thus,  endocytosis  of Factor  Xa 
bound  to  its  specific  endothelial  cell  sites  may  be  an  important  factor  in  the 
balance of vessel wall hemostatic mechanisms. 
We thank Dr. S. Silverstein for advice and encouragement in the completion of this work. 
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